Hormone Therapy News

Men with hypogonadism treated long-term with testosterone therapy experience improvements in sexual and urinary function compared with men who are not treated, according to findings published in The Journal of Urology.

Bisphosphonates and denosumab increased bone mineral density in men with nonmetastatic prostate cancer who received androgen deprivation therapy, according to findings published in Annals of Internal Medicine.

The decision by President Donald Trump to reinstitute a ban on transgender adults serving in the U.S. military, citing “tremendous medical costs,” has brought criticism from endocrinologists, who are quick to note that any treatment costs related to transgender care are far from excessive.

Transgender men initiating testosterone therapy via subcutaneous abdominal injections did not experience any change in free and total serum testosterone levels when compared with levels measured during previous intramuscular testosterone injections, study data show.

Long-term cross-sex hormone therapy for transgender individuals is associated with potential cardiovascular risks, but also offers psychological benefits, according to a review published in Annals of Internal Medicine.

A high proportion of transgender women with HIV who were surveyed said they did not adhere to either ART, feminizing hormone therapy or both for fear of drug interactions, according to researchers.

In the Department of Veterans Affairs health care system, prescriptions for testosterone are more likely to be written by younger providers, those with less professional experience and those in the endocrinology and urology fields compared with older providers, those with more experience and those in primary care, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

The decision to initiate hormone therapy in symptomatic, postmenopausal women should be based on a woman’s individual risk factors for cardiovascular disease, age and time from menopause, in addition to other factors, according to an updated position statement issued by the American Association of Clinical Endocrinologists and the American College of Endocrinology.

Researchers in Italy report adherence to recombinant growth hormone therapy remains a major problem among children with growth disorders. Based on their findings, they suggest pediatric endocrinologists annually assess treatment adherence among patients treated with growth hormone.

New data revealed an association between postmenopausal estrogen use and a reduced risk for hepatocellular carcinoma and increased overall survival time in women with HCC.